Metastasis Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Invasion

A

growth by infiltration and destruction of surrounding tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Metastasis

A

spread of tumour to (and growth at) ectopic sites, via blood, lymphatics, intra-epithelial route, or trans-coelomic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Carcinoma

A

Malignant tumour derived from epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sarcoma

A

Malignant tumour derived from mesenchymal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Melanoma

A

Malignant tumour derived from neural crest cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Leukaemia

A

Malignant tumour derived from circulating white blood cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lymphoma

A

Malignant tumour derived from the lymphatic system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

7 properties of metastatic tumours

A
  1. reduced cell-cell adhesion
  2. altered cell-substratum adhesion
  3. increased motility
  4. increased proteolytic ability
  5. angiogenic ability
  6. ability to intravasate and extravasate
  7. ability to proliferate (locally and in ectopic sites)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the basement membrane

A
  • secreted by basal epithelial cells/ endothelial cells
  • a layer of extracellular matrix (ECM) fibronectin,
  • type IV collagen, laminin, etc. a barrier to spread
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

where do breast tumour commonly migrate to

A

bone, lungs, liver, brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

where do lung adenocarcinomacommonly migrate to

A

bone, brain, adrenal glands, liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

where do skin melanoma commonly migrate to

A

Lungs, brain, skin, liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

where do colorectal tumour commonly migrate to

A

liver and lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

where do pancreatic tumour commonly migrate to

A

Liver and lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

where do prostate tumour commonly migrate to

A

Bones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

where do sarcoma commonly migrate to

A

Lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

where do uveal melanoma commonly migrate to

A

Liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Serine proteases

A

urokinase plasminogen activator (uPA), plasmin bind to receptors on tumour cell surface (uPAR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Matrix metalloproteinases (MMPs)


A
  • collagenases, gelatinases, stromelysins , membrane-type (MT)-MMPs
- soluble forms with ECM homology can bind to integrins e.g., MMP-2 binds to avb3 - produced by WBCs, associated with tissue / wound repair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

2 types of proteases

A

Serine proteases

Matrix metalloproteinases (MMPs)


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

C-met is a tumour component. what is its stromal component?

A

HGF

22
Q

Chemokine receptor is a tumour component. what is its stromal component?

A

Chemokine

23
Q

Protease receptor is a tumour component. what is its stromal component?

A

Protease

24
Q

Intergrin alpha v beta 3 is a tumour component. what is its stromal component?

A

MMP-2

25
Q

TGF is a tumour component. what is its stromal component?

A

Stromelysin

26
Q

VEGF is a tumour component. what is its stromal component?

A

VEGFR

27
Q

what is secreted by cells in the tumour microenvironment

A

growth factors, chemokines, enzymes 


28
Q

what acilitates tumour-stomal interactions

A

The tumour microenvironment

29
Q

4 cells in the tumour microenvironment

A

cancer-associated fibroblasts (CAFs)

immune cells that have infiltrated the tumour

myofibroblasts

tumour-associated vasculature pericytes 


30
Q

3 possible mechanisms of Cell-substratum : integrins

A

↓ adhesion to BM surrounding epithelium


↑ migration through stroma


↑ adhesion to BM or endothelial cells of BVs

31
Q

who do tumours bind selectively to endothelium of target organs

A

selectins

CD44 variants

32
Q

how do cells grow at metastatic site

A

Selective response to GFs at ectopic site

PTHRP and IL-11

33
Q

factor inducing cells to dissociate

A

HGF/scatter

34
Q

what is HGF

A
  • a mitogen (growth factor and a mitogen (Mobility factor)
  • morphogen with a developmental role (eg in migration of limb buds)
  • produced by stroll cells in a tumour (tumour microenvironment)
35
Q

what does HGF bind to

A

c-met, a RTK on tumour epithelial cells

36
Q

what does HGF/c-met activate

A
  • increase of tyrosine
  • phosphorylation of beta-catenin in tumour epithelial cells = disrupted ECD-mediated adhesion
37
Q

4 stages of white blood cell extravasation

A
  1. rolling
  2. activation
  3. adhesion
  4. diapedesis
38
Q

local angiogenic factors versus systemic anti-angiogenic factors

A

angiostatin & endostatin

39
Q

specific interns promoting invasion and metastasis

A

vitronectin receptor (integrin avb3)

40
Q

integrins bind CAMs in other cell types

A

heterotypic adhesion

41
Q

what are ingrains

A
  • cell adhesion molecules (CAMs)
  • integral to plasma membrane
  • bind to ECM molecules found in basal epithelial cells & in focal adhesions of migrating cells
42
Q

what to integrins typically bind to

A

ECM

43
Q

2 mutations which indirectly perturb ECD

A
  • proteins that interact with ECD (b-catenin, APC)
  • transcription factors that regulate E-cadherin (snail, slug, twist)
44
Q

Possible mechanisms for organ tropism

A
  • Selective migration to CK source (differential CKR expression)
  • Factors released by tumour / other cells cause changes in prospective TME at secondary sites, creating pre-metastatic niche
45
Q

• ‘exon-skipping’ in diffuse-type gastric tumours

A

lacking exons that encode Ca2+-binding domain

46
Q

Aberrant ECD expression in human tumours

A

inverse correlation between ECD expression and tumour grade

47
Q
A
48
Q
A
49
Q
A
50
Q
A
51
Q
A
52
Q
A